{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T05:58:43Z","timestamp":1721023123263},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Central-Level Non-profit Scientific Research Institutes Special Funds","award":["HSY201204"],"award-info":[{"award-number":["HSY201204"]}]},{"DOI":"10.13039\/501100005046","name":"Heilongjiang Provincial Natural Science Fund","doi-asserted-by":"crossref","award":["C201322"],"award-info":[{"award-number":["C201322"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.intimp.2014.12.011","type":"journal-article","created":{"date-parts":[[2014,12,16]],"date-time":"2014-12-16T18:00:40Z","timestamp":1418752840000},"page":"463-473","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Bi-specific antibodies with high antigen-binding affinity identified by flow cytometry"],"prefix":"10.1016","volume":"24","author":[{"given":"Liming","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingzhuang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingcui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2014.12.011_bb0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1389-0344(01)00083-1","article-title":"Bispecific and bifunctional single chain recombinant antibodies","volume":"18","author":"Kriangkum","year":"2001","journal-title":"Biomol Eng"},{"key":"10.1016\/j.intimp.2014.12.011_bb0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/11530960-000000000-00000","article-title":"Bispecific antibodies for cancer immunotherapy: current perspectives","volume":"24","author":"Muller","year":"2010","journal-title":"BioDrugs"},{"key":"10.1016\/j.intimp.2014.12.011_bb0015","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1126\/science.1165480","article-title":"Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site","volume":"323","author":"Bostrom","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.intimp.2014.12.011_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-1759(00)00338-0","article-title":"Introduction: bispecific antibodies","volume":"248","author":"Segal","year":"2001","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.intimp.2014.12.011_bb0025","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0167-5699(00)01659-5","article-title":"Immunotherapeutic perspective for bispecific antibodies","volume":"21","author":"van Spriel","year":"2000","journal-title":"Immunol Today"},{"key":"10.1016\/j.intimp.2014.12.011_bb0030","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s002620050430","article-title":"Redirected cellular cytotoxicity employing bispecific antibodies and other multifunctional binding proteins","volume":"45","author":"Weiner","year":"1997","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.intimp.2014.12.011_bb0035","doi-asserted-by":"crossref","first-page":"19665","DOI":"10.1074\/jbc.M500815200","article-title":"A fully human recombinant IgG-like bispecific antibody to both the epidermal growth factor receptor and the insulin-like growth factor receptor for enhanced antitumor activity","volume":"280","author":"Lu","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2014.12.011_bb0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/978-1-59745-554-1_20","article-title":"Construction and production of an IgG-like tetravalent bispecific antibody for enhanced therapeutic efficacy","volume":"525","author":"Lu","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.intimp.2014.12.011_bb0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-62703-586-6_11","article-title":"Construction and production of an IgG-Like tetravalent bispecific antibody, IgG-single-chain Fv fusion","volume":"1060","author":"Lu","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.intimp.2014.12.011_bb0050","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.intimp.2012.10.005","article-title":"A bispecific antibody against IL-1beta and IL-17A is beneficial for experimental rheumatoid arthritis","volume":"14","author":"Qi","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2014.12.011_bb0055","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jmb.2010.04.001","article-title":"Effector cell recruitment with novel Fv-based dual-affinity re-targeting protein leads to potent tumor cytolysis and in vivo B-cell depletion","volume":"399","author":"Johnson","year":"2010","journal-title":"J Mol Biol"},{"key":"10.1016\/j.intimp.2014.12.011_bb0060","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-2141.2010.08300.x","article-title":"A recombinant trispecific single-chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targeting","volume":"150","author":"Kugler","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.intimp.2014.12.011_bb0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4161\/mabs.3.1.14057","article-title":"A single-chain triplebody with specificity for CD19 and CD33 mediates effective lysis of mixed lineage leukemia cells by dual targeting","volume":"3","author":"Schubert","year":"2011","journal-title":"MAbs"},{"key":"10.1016\/j.intimp.2014.12.011_bb0070","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/CJI.0b013e3181dda225","article-title":"Effective elimination of acute myeloid leukemic cells by recombinant bispecific antibody derivatives directed against CD33 and CD16","volume":"33","author":"Singer","year":"2010","journal-title":"J Immunother"},{"key":"10.1016\/j.intimp.2014.12.011_bb0075","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4161\/mabs.1.6.10015","article-title":"Bispecific antibodies for cancer therapy: the light at the end of the tunnel?","volume":"1","author":"Chames","year":"2009","journal-title":"MAbs"},{"key":"10.1016\/j.intimp.2014.12.011_bb0080","doi-asserted-by":"crossref","first-page":"9193","DOI":"10.1073\/pnas.0400187101","article-title":"Anchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries","volume":"101","author":"Harvey","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2014.12.011_bb0085","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jim.2005.09.017","article-title":"Engineering of recombinant antibody fragments to methamphetamine by anchored periplasmic expression","volume":"308","author":"Harvey","year":"2006","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.intimp.2014.12.011_bb0090","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.intimp.2012.12.010","article-title":"Synergistic effects of interleukin-1beta and interleukin-17A antibodies on collagen-induced arthritis mouse model","volume":"15","author":"Zhang","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2014.12.011_bb0095","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jim.2005.11.021","article-title":"Isolation of cell specific peptide ligands using fluorescent bacterial display libraries","volume":"309","author":"Dane","year":"2006","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.intimp.2014.12.011_bb0100","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/bit.21405","article-title":"Binding and enrichment of Escherichia coli spheroplasts expressing inner membrane tethered scFv antibodies on surface immobilized antigens","volume":"98","author":"Jung","year":"2007","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.intimp.2014.12.011_bb0105","first-page":"1090","article-title":"Establishment of bacteria display technology for Fab antibody library screening","volume":"27","author":"Xu","year":"2011","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"10.1016\/j.intimp.2014.12.011_bb0110","doi-asserted-by":"crossref","first-page":"8247","DOI":"10.1073\/pnas.0702650104","article-title":"APEx 2-hybrid, a quantitative protein-protein interaction assay for antibody discovery and engineering","volume":"104","author":"Jeong","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2014.12.011_bb0115","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2174\/138920101131400223","article-title":"A Neutralization scFv Antibody against IL-1beta Isolated from a NIPA-based Bacterial Display Library","volume":"14","author":"Li","year":"2013","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.intimp.2014.12.011_bb0120","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00002281-200105000-00003","article-title":"Anti-tumor necrosis factor therapies","volume":"13","author":"Taylor","year":"2001","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl. 3","key":"10.1016\/j.intimp.2014.12.011_bb0125","first-page":"iii17","article-title":"The impact of new biologicals in the treatment of rheumatoid arthritis","volume":"43","author":"Weaver","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.intimp.2014.12.011_bb0130","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jim.2005.04.016","article-title":"Affinity ranking of antibodies using flow cytometry: application in antibody phage display-based target discovery","volume":"302","author":"Geuijen","year":"2005","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.intimp.2014.12.011_bb0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-2567.2001.01148.x","article-title":"Functional activity of CD40 antibodies correlates to the position of binding relative to CD154","volume":"102","author":"Barr","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2014.12.011_bb0140","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0022-1759(96)00227-X","article-title":"Determination of the binding affinity of an anti-CD34 single-chain antibody using a novel, flow cytometry based assay","volume":"201","author":"Benedict","year":"1997","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.intimp.2014.12.011_bb0145","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10529-013-1400-6","article-title":"Anchored periplasmic expression (APEx)-based bacterial display for rapid and high-throughput screening of B cell epitopes","volume":"36","author":"Guo","year":"2014","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.intimp.2014.12.011_bb0150","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.joca.2011.01.018","article-title":"IL-17RA aptamer-mediated repression of IL-6 inhibits synovium inflammation in a murine model of osteoarthritis","volume":"19","author":"Chen","year":"2011","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.intimp.2014.12.011_bb0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.intimp.2014.04.018","article-title":"Therapeutic efficacy of three bispecific antibodies on collagen-induced arthritis mouse model","volume":"21","author":"Li","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2014.12.011_bb0160","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/cmi.2010.22","article-title":"The cytokine milieu in the interplay of pathogenic Th1\/Th17 cells and regulatory T cells in autoimmune disease","volume":"7","author":"Leung","year":"2010","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.intimp.2014.12.011_bb0165","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1681\/ASN.2008080891","article-title":"IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen","volume":"20","author":"Ooi","year":"2009","journal-title":"J Am Soc Nephrol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914004792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576914004792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T19:25:42Z","timestamp":1537989942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576914004792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1567576914004792"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2014.12.011","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bi-specific antibodies with high antigen-binding affinity identified by flow cytometry","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2014.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}